Suchergebnis | Hamburg Open Science

Facetten

32 Einträge gefunden

Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.
2012 - Forschungsinformationssystem des UKE
Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.
2009 - Forschungsinformationssystem des UKE
Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
2009 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
2008 - Forschungsinformationssystem des UKE
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.
2008 - Forschungsinformationssystem des UKE
Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.
2008 - Forschungsinformationssystem des UKE
Molecular cancer phenotype in normal prostate tissue.
2008 - Forschungsinformationssystem des UKE
Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
2008 - Forschungsinformationssystem des UKE
Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.
2007 - Forschungsinformationssystem des UKE
Nerve distribution along the prostatic capsule.
2007 - Forschungsinformationssystem des UKE
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
2006 - Forschungsinformationssystem des UKE
Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.
2006 - Forschungsinformationssystem des UKE
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
2006 - Forschungsinformationssystem des UKE
Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.
2006 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

Prognostic relevance of Bcl-2 overexpression in surgically treated prostate cancer is not caused by increased copy number or translocation of the gene.

Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy series.

Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men.

Validation of the contemporary epstein criteria for insignificant prostate cancer in European men.

Molecular cancer phenotype in normal prostate tissue.

Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.

Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy.

Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.

Nerve distribution along the prostatic capsule.

High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.

Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.

Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

Frozen section for the management of intraoperatively detected palpable tumor lesions during nerve-sparing scheduled radical prostatectomy.